Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
CRISPR Therapeutics AGListing on record | Buy | $685.2K | conv 27 | SEC | |
CRISPR Therapeutics AGListing on record | Buy | $317K | conv 45First in 12mo | SEC | |
Altus Pharmaceuticals Inc.Listing unverified | Sell | $11.7M | SEC |